PRDX4 and hepatocellular carcinoma: Among 372 cases of HCC patients, the patients with PRDX6 genetic alterations were the most, 63 cases (18%), followed by PRDX3, with 41 cases (11%); the patients with PRDX1 and PRDX4 genetic alterations were the least, 26 cases (7%) each.